Bird Flu
Long Road Ahead in Developing Effective Avian Flu Vaccination Strategy, Stanford Expert Says
Published in TB and Outbreaks Week, March 6th, 2007
But developing a vaccine against one of the most talked about types of influenza--the H5, or avian flu--is proving to be more vexing than first thought.
"Making a vaccine for H5 is more difficult than anticipated, even beyond the necessity of making it on the fly," said Harry Greenberg, MD, the Joseph D. Grant Professor at the Stanford University School of Medicine. "At every level...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Bioterrorism
VIASYS Healthcare Supplies the State of California with 2,400 Ventilators for Emergency Preparedness Initiative - Bird Flu
ADVENTRX to Present Thiovir Preclinical Data at the 20th International Conference on Antiviral Research - Bird Flu
Flutrends Begins Operation With an Exclusive Focus on Influenza, a Goal to Reduce the Annual Impact and a Mission to Eradicate the Virus - Bird Flu
Hemispherx Avian Flu Prevention/Treatment Program Announces New Primate Results and Expands in both Europe and Southern Hemisphere - Epidemic
National Autism Association Renews Call for CDC to Declare Autism a National Emergency - HIV/AIDS
Merck & Co., Inc., Again Reduces Price of STOCRIN (efavirenz) for Patients in Least Developed Countries and Countries Hardest Hit by Epidemic - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
